Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)

Cary O. Harding, Shelley R. Winn, K. Michael Gibson, Erland Arning, Teodoro Bottiglieri, Markus Grompe

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)'. Together they form a unique fingerprint.

Medicine & Life Sciences